Panagora Asset Management Inc Halozyme Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$32.86 - $55.7 $250,557 - $424,712	-7,625 Reduced 30.04%	17,755 $678,000
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $327,049 - $485,268	-8,164 Reduced 24.34%	25,380 $1.44 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $149 - $193	4 Added 0.01%	33,544 $1.48 Million
Q4 2021 Feb 10, 2022	SELL	$31.82 - $40.75 $7,668 - $9,820	-241 Reduced 0.71%	33,540 $1.35 Million
Q2 2021 Aug 11, 2021	SELL	$38.84 - $51.31 $535,953 - $708,026	-13,799 Reduced 29.0%	33,781 $1.53 Million
Q1 2021 May 12, 2021	SELL	$39.51 - $51.45 $91,189 - $118,746	-2,308 Reduced 4.63%	47,580 $1.98 Million
Q4 2020 Feb 10, 2021	SELL	$25.81 - $43.62 $424,677 - $717,723	-16,454 Reduced 24.8%	49,888 $2.13 Million
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $5.76 Million - $6.63 Million	-223,628 Reduced 77.12%	66,342 $1.74 Million
Q2 2020 Aug 12, 2020	SELL	$16.25 - $26.81 $9.1 Million - $15 Million	-559,895 Reduced 65.88%	289,970 $7.77 Million
Q1 2020 May 14, 2020	SELL	$13.9 - $21.83 $6.99 Million - $11 Million	-503,076 Reduced 37.18%	849,865 $15.3 Million
Q4 2019 Feb 12, 2020	BUY	$14.93 - $19.53 $1.62 Million - $2.11 Million	108,275 Added 8.7%	1,352,941 $24 Million
Q3 2019 Nov 12, 2019	SELL	$15.2 - $17.69 $992,453 - $1.16 Million	-65,293 Reduced 4.98%	1,244,666 $19.3 Million
Q2 2019 Aug 09, 2019	BUY	$14.75 - $17.26 $1.2 Million - $1.41 Million	81,579 Added 6.64%	1,309,959 $22.5 Million
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $3.18 Million - $4.01 Million	228,321 Added 22.83%	1,228,380 $19.8 Million
Q4 2018 Feb 14, 2019	BUY	$13.33 - $18.66 $162,519 - $227,502	12,192 Added 1.23%	1,000,059 $14.6 Million
Q3 2018 Nov 13, 2018	BUY	$16.68 - $18.41 $1.82 Million - $2.01 Million	109,088 Added 12.41%	987,867 $18 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $2.45 Million - $2.94 Million	145,012 Added 19.76%	878,779 $14.8 Million
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $1.37 Million - $1.71 Million	-80,475 Reduced 9.88%	733,767 $14.4 Million
Q4 2017 Feb 14, 2018	SELL	$16.75 - $20.8 $709,144 - $880,609	-42,337 Reduced 4.94%	814,242 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $10.1 Million - $14.9 Million	856,579	856,579 $14.9 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account